These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 29774124)

  • 1. The cellular composition of the tumor microenvironment is an important marker for predicting therapeutic efficacy in breast cancer.
    Dou T; Li J; Zhang Y; Pei W; Zhang B; Wang B; Wang Y; Jia H
    Front Immunol; 2024; 15():1368687. PubMed ID: 38487526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic interactions in the tumor niche: how the cross-talk between CAFs and the tumor microenvironment impacts resistance to therapy.
    Piwocka O; Piotrowski I; Suchorska WM; Kulcenty K
    Front Mol Biosci; 2024; 11():1343523. PubMed ID: 38455762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A CAF-Fueled TIMP-1/CD63/ITGB1/STAT3 Feedback Loop Promotes Migration and Growth of Breast Cancer Cells.
    Dittmer A; Dittmer J
    Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological effects and regulation of IGFBP5 in breast cancer.
    Dittmer J
    Front Endocrinol (Lausanne); 2022; 13():983793. PubMed ID: 36093095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCL3 expression is strongly associated with the occurrence of breast cancer relapse under tamoxifen treatment in a retrospective cohort study.
    Czapiewski P; Cornelius M; Hartig R; Kalinski T; Haybaeck J; Dittmer A; Dittmer J; Ignatov A; Nass N
    Virchows Arch; 2022 Mar; 480(3):529-541. PubMed ID: 35020071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear Mechanisms Involved in Endocrine Resistance.
    Dittmer J
    Front Oncol; 2021; 11():736597. PubMed ID: 34604071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent Inflammatory Stimulation Drives the Conversion of MSCs to Inflammatory CAFs That Promote Pro-Metastatic Characteristics in Breast Cancer Cells.
    Rubinstein-Achiasaf L; Morein D; Ben-Yaakov H; Liubomirski Y; Meshel T; Elbaz E; Dorot O; Pichinuk E; Gershovits M; Weil M; Ben-Baruch A
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33806906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinoma-Associated Fibroblasts Promote Growth of Sox2-Expressing Breast Cancer Cells.
    Dittmer A; Dittmer J
    Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33228022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein‑ and growth‑modulatory effects of carcinoma‑associated fibroblasts on breast cancer cells: Role of interleukin‑6.
    Dittmer A; Lange T; Leyh B; Dittmer J
    Int J Oncol; 2020 Jan; 56(1):258-272. PubMed ID: 31789400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast Cancer Tumor Stroma: Cellular Components, Phenotypic Heterogeneity, Intercellular Communication, Prognostic Implications and Therapeutic Opportunities.
    Eiro N; Gonzalez LO; Fraile M; Cid S; Schneider J; Vizoso FJ
    Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31086100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of intratumoral stromal proteins is associated with chemotherapy resistance in breast cancer.
    Wang T; Srivastava S; Hartman M; Buhari SA; Chan CW; Iau P; Khin LW; Wong A; Tan SH; Goh BC; Lee SC
    Oncotarget; 2016 Aug; 7(34):55155-55168. PubMed ID: 27487140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of tamoxifen and fulvestrant long-term treatments on ROS production and (pro/anti)-oxidant enzymes mRNA levels in a MCF-7-derived breast cancer cell line.
    Badia E; Morena M; Lauret C; Boulahtouf A; Boulle N; Cavaillès V; Balaguer P; Cristol JP
    Breast Cancer; 2016 Sep; 23(5):692-700. PubMed ID: 26193841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function.
    Martinez-Outschoorn U; Sotgia F; Lisanti MP
    Semin Oncol; 2014 Apr; 41(2):195-216. PubMed ID: 24787293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term exposure to carcinoma-associated fibroblasts makes breast cancer cells addictive to integrin β1.
    Dittmer A; Dittmer J
    Oncotarget; 2018 Apr; 9(31):22079-22094. PubMed ID: 29774124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stromal cells promote anti-estrogen resistance of breast cancer cells through an insulin-like growth factor binding protein 5 (IGFBP5)/B-cell leukemia/lymphoma 3 (Bcl-3) axis.
    Leyh B; Dittmer A; Lange T; Martens JW; Dittmer J
    Oncotarget; 2015 Nov; 6(36):39307-28. PubMed ID: 26515727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
    Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G
    Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.